Philip Morris Intlの空売り状況は、投資家がPhilip Morris Intlの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Philip Morris Intl (NYSE:PM) 株価情報, 空売り情報

Philip Morris Intl

Created from the international operations of Altria in 2008, Philip Morris International sells cigarettes and reduced-risk products, including heatsticks, vapes, and oral nicotine offerings primarily outside of the US. With the 2022 acquisition of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches primarily in the US and Scandinavia, PMI has not only diversified away from smokeable products but also gained a toehold into the US to sell its iQOS heatsticks.

Philip Morris International Inc Common Stock

Philip Morris International Inc

Plasmatech Inc

Innovator U.S. Equity Power Buffer ETF - March

PREMIER INVESTMENTS LTD by Premier Investments Ltd.

Premier Investments Ltd

Powell Max Limited - Class A Ordinary Shares

Powell Max Ltd

Innovator U.S. Equity Power Buffer ETF - May

Pharmala Biotech Holdings Inc

PROMOTORA AMBIENTAL SAB B by Promotora Ambiental SAB de CV

Promotora Ambiental SAB de CV

PEMBINA PPLNE PFD A SER 7 by Pembina Pipeline Corp.

Pembina Pipeline Corp

PIMCO Mortgage-Backed Securities Active Exchange-Traded Fund

PMB AEROSPACE CORP by PMB Aerospace Corporation

PMB Aerospace Corp

PharmaCyte Biotech Inc

PELOTON MINERALS CORP by Peloton Minerals Corporation

Peloton Minerals Corp

PT MERDEKA COPPER GLD TBK by PT MERDEKA COPPER GOLD TBK

PT Merdeka Copper Gold Tbk

Prospector Metals Corp

PROSPECTOR METALS CORP by PROSPECTOR METALS CORP.

Pro Medicus Ltd

Psychemedics Corp.

PSYCHEMEDICS CORP NEW by Psychemedics Corp.

Psychemedics Corp

PRO MEDICUS LTD U/ADR by Pro Medicus, Ltd.

PT MITRA ADIPERKASA TBK by Pt Mitra Adiperkasa Tbk

PT Mitra Adiperkasa Tbk

PT MITRA ADIPERKASA S/ADR by Pt Mitra Adiperkasa Tbk

PACE MEDICAL INC by Pace Medical, Inc.

PLATEAU MINERAL DEV INC by Plateau Mineral Development, Inc.

Plateau Mineral Development Inc

Sonoran Desert Copper Corp

SONORAN DESERT COPPER CP by SONORAN DESERT COPPER CORP

PHARMA FOODS INTL CO by Pharma Foods International Co., Ltd.

Pharma Foods International Co Ltd

PM&E Inc

Primech Holdings Ltd

PREDICTMEDIX AI INC by PREDICTMEDIX AI INC.

Predictmedix AI Inc

PATRIOT BATTERY METALS by PATRIOT BATTERY METALS INC

Patriot Battery Metals Inc

PIMCO Municipal Income Fund

Priveterra Acquisition Corp II Ordinary Shares - Class A

Priveterra Acquisition Corp II

Priveterra Acquisition Corp II Units (1 Ord Class A & 1/2 War)

Priveterra Acquisition Corp II Warrants (02/12/2025)

Perth Mint Gold Token

Perpetual Energy Inc

PRIME MERIDIAN HLDG CO by Prime Meridian Holding Co.

Prime Meridian Holding Co

PERFECT MED HLTH U/ADR by PERFECT MED HEALTH MGMT LTD.

POLOMAR HEALTH SVCS INC by Polomar Health Services, Inc.

Polomar Health Services Inc

PLASMA INNOVATIVE INC by PLASMA INNOVATIVE INC.

Plasma Innovative Inc

PGIM ETF Trust PGIM Municipal Income Opportunities ETF

PMI GROUP INC NEW by PMI Group, Inc. (The)

PMI Group Inc

PT MULTI INDOCITRA ORD by PT Multi Indocitra Tbk

PGIM Rock ETF Trust PGIM S&P 500 Max Buffer ETF - January

PT Merck Tbk

Playmaker Capital Inc Ordinary Shares

PINKMONKEY.COM INC by PinkMonkey.com, Inc.

PinkMonkey.com Inc

Pimco Municipal Income Fund II Common Shares of Beneficial Interest

PIMCO Municipal Income Fund II

Putnam Managed Municipal Income Trust Common Stock

Putnam Managed Municipal Income Trust

PUMA AG RUDOLF DASSLER SP by Puma AG Rudolf Dassler Sport

Puma SE

PEMBINA PIPELINE CORP PFD by Pembina Pipeline Corp.

Pampa Metals Corp Ordinary Shares

PAMPA METALS CORP by Pampa Metals Corporation

Pampa Metals Corp

PREMIUM EXPL INC by Premium Exploration, Inc.

Premium Exploration Inc

PREMIUM GROUP CO LTD by PREMIUM GROUP CO LTD.

Premium Group Co Ltd

Precious Metals and Mining Trust

ProMIS Neurosciences Inc. - Common Shares

ProMIS Neurosciences Inc

Perfect Moment Ltd

PERSEUS MINING LTD ORD by Perseus Mining Ltd

Perseus Mining Ltd

Putnam Municipal Opportunities Trust Common Stock

Putnam Municipal Opportunities Trust

Harbour Energy PLC

Prismo Metals Inc

Polychain Monsters

PRISMONE GROUP INC by PrismOne Group, Inc.

PREMIER PRODUCTS GROUP by Premier Products Group, Inc.

Premier Products Group Inc

Primaris REIT

POP MART INTL UNSP/ADR by Pop Mart International Group Limited

Pop Mart International Group Ltd

PROTEOME SCIENCES PLC by Proteome Sciences PLC

Proteome Sciences PLC

PRIMAL SOLUTIONS INC by Primal Solutions, Inc.

Primal Solutions Inc

PennyMac Mortgage Investment Trust Common Shares of Beneficial Interest

PennyMac Mortgage Investment Trust

PACIFIC METALS CO LTD by Pacific Metals Co., Ltd.

Pacific Metals Co Ltd

PRECIOUS MTLS BULLION TR by Precious Metals Bullion Trust

CPI Card Group Inc

PennyMac Mortgage Investment Trust 8.50% Senior Notes due 2028

PLAYMATES TOYS LTD ORD by Playmates Toys Ltd.

Playmates Toys Ltd

PennyMac Mortgage Investment Trust 8.125% Series A Fixed-to-Floating Rate Cumulative Redeemable Preferred Shares of Beneficial Interest

PennyMac Mortgage Investment Trust 8.00% Series B Fixed-to-Floating Rate Cumulative Redeemable Preferred Shares of Beneficial Interest

PennyMac Mortgage Investment Trust 6.75% Series C Cumulative Redeemable Preferred Shares of Beneficial Interest

PMV CONSUMER ACQ CORP A by PMV Consumer Acquisition Corp.

PMV CONSUMER ACQ A NEW by PMV Consumer Acquisition Corp.

PMV Consumer Acquisition Corp

PMV Consumer Acquisition Corp Warrants (31/08/2027)

PMV Pharmaceuticals Inc

PIMCO Municipal Income Fund III Common Shares of Beneficial Interest

PIMCO Municipal Income Fund III

SYNTARA LTD by SYNTARA LTD.

Primix Corp

Boab Metals Ltd

The U.S. Food and Drug Administration (FDA) has granted marketing authorization for 20 nicotine pouch products from ZYN, a <a href="https://www.benzinga.com/pressreleases/25/01/b43037438/fda-authorizes-all-zyn-nicotine-pouch-products-currently-marketed-by-swedish-match-in-the-u-s">brand of nicotine products</a> from Philip Morris International Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>). 
The ZYN nicotine pouches, small sachets containing nicotine meant to be placed between the gum and lip, are the first products of their kind to gain FDA approval.
This decision follows an extensive review, confirming that the ZYN nicotine pouches comply with the public health criteria set by the 2009 <a href="https://www.fda.gov/news-events/press-announcements/fda-authorizes-marketing-20-zyn-nicotine-pouch-products-after-extensive-scientific-review#:~:text=Today%2C%20the%20U.S.%20Food%20and,following%20an%20extensive%20scientific%20review.">Family Smoking Prevention and Tobacco Control Act</a>.
These standards assess the risks and benefits of tobacco products, especially concerning the overall population&#8217;s health.
The FDA&#8217;s assessment showed that these products present lower health risks than cigarettes and other smokeless tobacco items such as snus and moist snuff, due to their reduced levels of harmful chemicals. 
FDA specialists noted that these products could be beneficial for adults who fully transition from cigarettes and smokeless tobacco. 
The FDA also observed that, despite the rise in sales of these products in recent years, the likelihood of youth usage remains minimal.
Also Read: <a href="https://www.benzinga.com/news/25/01/43023778/gm-vianode-strike-multi-billion-anode-graphite-supply-deal-details">GM, Vianode Strike Multi-Billion Anode Graphite Supply Deal: Details</a>
The 2024 National Youth Tobacco Survey revealed that just 1.8% of U.S. middle and high school students reported using nicotine pouches.
"It's critical that the manufacturer market these products responsibly to prevent youth use," said director of the FDA's Center for Tobacco Products, Brian King.
Strict rules have been established to guarantee that ZYN nicotine pouch ads are directed solely at adults aged 21 and over.
The FDA also specified further precautions, including restricting mass media advertising and mandating that actors in commercials be at least 35 years old or made to appear that age. 
Additionally, the FDA emphasized that although these products are approved for sale, they are not deemed safe and the agency will keep monitoring their effect on public health.
The approved nicotine pouch products include flavors such as ZYN Chill, ZYN Cinnamon, ZYN Cool Mint and others, each available in 3 mg and 6 mg strengths.
The FDA&#8217;s approval applies solely to these products and does not cover other nicotine pouches or similar items made by ZYN.
The company is not allowed to assert reduced risk claims for these products unless it files a separate application for a modified risk tobacco product.
Price Action: PM shares closed higher by 1.08% at $119.80 on Thursday.
Photo: Shutterstock

News

General

ZYN Nicotine Pouches Receive FDA Marketing Approval

<a href="https://www.fda.gov/news-events/press-announcements/fda-authorizes-marketing-20-zyn-nicotine-pouch-products-after-extensive-scientific-review#:~:text=Today%2C%20the%20U.S.%20Food%20and,following%20an%20extensive%20scientific%20review.">https://www.fda.gov/news-events/press-announcements/fda-authorizes-marketing-20-zyn-nicotine-pouch-products-after-extensive-scientific-review#:~:text=Today%2C%20the%20U.S.%20Food%20and,following%20an%20extensive%20scientific%20review.</a>
&nbsp;
Today, the U.S. Food and Drug Administration authorized the marketing of 20 ZYN nicotine pouch products through the <a href="https://www.fda.gov/tobacco-products/market-and-distribute-tobacco-product/premarket-tobacco-product-applications">premarket tobacco product application (PMTA)</a> pathway following an extensive scientific review. This is the first time the agency has authorized products commonly referred to as <a href="https://www.fda.gov/tobacco-products/market-and-distribute-tobacco-product/premarket-tobacco-product-applications">nicotine pouches</a>, which are small synthetic fiber pouches containing nicotine designed to be placed between a person's gum and lip. &nbsp;
The FDA determined that the specific products receiving marketing authorization met the <a href="https://www.fda.gov/tobacco-products/market-and-distribute-tobacco-product/premarket-tobacco-product-applications">public health standard</a> legally required by the 2009 Family Smoking Prevention and Tobacco Control Act. This standard considers the risks and benefits of products to the population as a whole.&nbsp;
Among several key considerations, the agency's evaluation showed that, due to substantially lower amounts of harmful constituents than cigarettes and most smokeless tobacco products, such as moist snuff and snus, the authorized products pose lower risk of cancer and other serious health conditions than such products. The applicant also provided evidence from a study showing that a substantial proportion of adults who use cigarette and/or smokeless tobacco products completely switched to the newly authorized nicotine pouch products.

XXII

FDA Authorizes Marketing Of 20 ZYN Nicotine Pouch Products after Extensive Scientific Review

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>JP Morgan analyst Zach Parham initiated coverage on Expand Energy Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXE#NASDAQ">EXE</a>) with an Overweight rating and announced a price target of $112. Expand Energy shares closed at $105.24 on Wednesday. <a href="https://www.benzinga.com/quote/EXE/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Loop Capital analyst Chris Dankert initiated coverage on Genuine Parts Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPC#NYSE">GPC</a>) with a Buy rating and announced a price target of $155. Genuine Parts shares closed at $117.38 on Wednesday. <a href="https://www.benzinga.com/quote/GPC/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Morgan Stanley analyst Eric Serotta initiated coverage on Altria Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MO#NYSE">MO</a>) with an Equal-Weight rating and announced a price target of $54. Altria Group shares closed at $51.04 on Wednesday. <a href="https://www.benzinga.com/quote/MO/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Stifel analyst Suthan Sukumar initiated coverage on TELUS International (Cda) Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TIXT#NYSE">TIXT</a>) with a Buy rating and announced a price target of $5. TELUS shares closed at $3.35 on Wednesday. <a href="https://www.benzinga.com/quote/TIXT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Morgan Stanley analyst Eric Serotta initiated coverage on Philip Morris International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) with an Overweight rating and announced a price target of $140. Philip Morris shares closed at $118.51 on Wednesday. <a href="https://www.benzinga.com/quote/PM/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying PM stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="561" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16092122/image-111-1024x561.png" alt="" class="wp-image-736922" style="width:560px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16092122/image-111-1024x561.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16092122/image-111-300x164.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16092122/image-111-768x421.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16092122/image-111.png 1191w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/01/43026927/how-to-earn-500-a-month-from-j-b-hunt-transport-stock-ahead-of-q4-earnings">How To Earn $500 A Month From J.B. Hunt Transport Stock Ahead Of Q4 Earnings</a></li>
</ul>

Initiation

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

TIXT

This Philip Morris International Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Morgan Stanley analyst Eric Serotta initiates coverage on Philip Morris Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) with a Overweight rating and announces Price Target of $140.

Price Target

Morgan Stanley Initiates Coverage On Philip Morris Intl with Overweight Rating, Announces Price Target of $140

<a href="https://www.fda.gov/news-events/press-announcements/fda-proposes-significant-step-toward-reducing-nicotine-minimally-or-nonaddictive-level-cigarettes#:~:text=The%20FDA%20is%20proposing%20to,products%20on%20the%20market%20today" title="https://www.fda.gov/news-events/press-announcements/fda-proposes-significant-step-toward-reducing-nicotine-minimally-or-nonaddictive-level-cigarettes#:~:text=The%20FDA%20is%20proposing%20to,products%20on%20the%20market%20today">https://www.fda.gov/news-events/press-announcements/fda-proposes-significant-step-toward-reducing-nicotine-minimally-or-nonaddictive-level-cigarettes#:~:text=The%20FDA%20is%20proposing%20to,products%20on%20the%20market%20today</a>

Biotech

Government

Regulations

'FDA Proposes Significant Step Toward Reducing Nicotine To Minimally Or Nonaddictive Level In Cigarettes And Certain Other Combusted Tobacco Products' - FDA

Philip Morris Intl's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) short percent of float has risen 23.73% since its last report. The company recently reported that it has 11.39 million shares sold short, which is 0.73% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.32 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Philip Morris Intl Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736538315_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Philip Morris Intl has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Philip Morris Intl's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Philip Morris Intl's peer group average for short interest as a percentage of float is 1.81%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

(PM) - Analyzing Philip Morris Intl's Short Interest

Barclays analyst Gaurav Jain maintains Philip Morris Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) with a Overweight and lowers the price target from $155 to $145.

Barclays Maintains Overweight on Philip Morris Intl, Lowers Price Target to $145

<a href="https://www.nytimes.com/2024/12/11/health/fda-low-nicotine-cigarettes-biden.html" title="https://www.nytimes.com/2024/12/11/health/fda-low-nicotine-cigarettes-biden.html">https://www.nytimes.com/2024/12/11/health/fda-low-nicotine-cigarettes-biden.html</a>

"F.D.A. Tries Last-Ditch Move to Slash Nicotine Levels in Cigarettes; The agency is asking the White House to move ahead with plans to drastically reduce the addictive substance in traditional tobacco cigarettes." - NY Times

Lilly CEO Says To Test Obesity Drugs For Smoking, Alcohol Abuse

U.S. Supreme Court Declines To Decide Whether Certain Federally Mandated Health Warnings On Cigarette Packs Violate Tobacco Companies' Free Speech Protections

Philip Morris Intl's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) short percent of float has risen 22.64% since its last report. The company recently reported that it has 10.02 million shares sold short, which is 0.65% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.79 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Philip Morris Intl Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732298415_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Philip Morris Intl has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Philip Morris Intl's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Philip Morris Intl's peer group average for short interest as a percentage of float is 1.72%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Looking Into Philip Morris Intl's Recent Short Interest

As President-elect Donald Trump prepares to return to the White House, renowned economist Mohamed El-Erian is cautioning against media oversimplification of the incoming administration&#8217;s proposed tariff strategies.
What Happened: In a recent statement on X, El-Erian highlighted the intricate nature of Trump&#8217;s tariff discussions, noting that the proposed economic policies encompass at least three complex economic stages influenced by multiple factors, including trade flows, corporate pricing strategies, and geopolitical considerations.
El-Erian&#8217;s core message remains clear: Trump&#8217;s tariff debate requires sophisticated, nuanced analysis that transcends simplistic narratives. &#8220;The issue is quite complex,&#8221; he emphasized, underscoring the need for comprehensive economic understanding beyond headline rhetoric.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">It should come as no surprise that the media tends to oversimplify the U.S. tariff debate, with both sides of the argument contributing to this. The issue is quite complex, involving at least three economic stages, each with various possibilities given the influences in play. The…
&mdash; Mohamed A. El-Erian (@elerianm) <a href="https://twitter.com/elerianm/status/1859287383075848351?ref_src=twsrc%5Etfw">November 20, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Trump&#8217;s proposed economic blueprint, which includes a universal tariff of up to 20% on imports and potentially up to 60% on Chinese goods, has sparked intense economic debate. Tech investor Peter Thiel suggests these tariffs could significantly impact Chinese companies while causing minimal <a href="https://www.benzinga.com/markets/24/11/42028954/peter-thiel-says-trumps-60-china-tariff-would-be-very-very-bad-for-beijing-heres-whats-at-stake">disruption to U.S. consumers</a>.
See Also: <a href="https://www.benzinga.com/24/11/42102366/bitcoin-taps-95k-ethereum-dogecoin-flat-as-trumps-crypto-policy-takes-shape-top-analyst-describes-btcs-path-to-135k">Bitcoin Hits $95K For The First Time Ever, Ethereum, Dogecoin Flat As Trump&#8217;s Crypto Policy Takes Shape: Top Analyst Describes BTC&#8217;s Path To $135K</a>
Why It Matters: Goldman Sachs economist David Mericle warns that Trump&#8217;s proposed universal tariff could push <a href="https://www.benzinga.com/economics/macro-economic-events/24/11/42042411/inflation-could-surge-to-3-if-trump-applies-universal-tariffs-goldman-sachs">inflation back to 3%</a>, potentially complicating Federal Reserve monetary strategies. 
The National Retail Federation estimates Trump&#8217;s tariff proposals could reduce annual consumer <a href="https://www.benzinga.com/news/24/11/41737933/trump-tariff-proposed-may-cost-americans-78b-in-spending-study">spending by $78 billion</a>.
Prominent business leaders have voiced concerns. Citadel LLC CEO Ken Griffin described Trump&#8217;s proposed tariffs as a &#8220;long, slippery slope&#8221; that <a href="https://www.benzinga.com/news/global/24/11/42056528/gop-megadonor-ken-griffin-warns-of-slippery-slope-in-trumps-tariff-policies-sees-us-returning-to-the-business-of-business">could hamper U.S. global competitiveness</a>. 
Retailers like AutoZone and Columbia Sportswear have signaled potential price increases that would be <a href="https://www.benzinga.com/news/24/11/41871407/trumps-tariffs-deportations-and-tax-cuts-may-push-prices-higher-experts-say-its-pretty-clear?utm_campaign=partner_feed&amp;utm_source=yahooFinance&amp;utm_medium=partner_feed&amp;utm_content=site&amp;nid=42027079">passed directly to consumers</a>.
"Tariffs would create a headwind to the performance of stocks with high international revenue exposure due to the risk of retaliatory tariffs and heightened geopolitical tensions," Goldman Sachs analyst David Kostin stated.
Goldman Sachs noted that <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/06/39467825/us-election-and-tariff-prospects-set-to-threaten-internationally-exposed-stocks-gol">U.S. stocks with domestic sales focus outperformed</a> those with international exposure by 1 percentage point the day after Trump's election and by 4 pp in the following month but underperformed by 9 pp in the next 12 months.
Key stocks in its Domestic Sales Basket include CVS Health Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>), Wells Fargo &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>), T-Mobile US Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMUS#NASDAQ">TMUS</a>), Verizon Communications Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>), Lowe's Cos. Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LOW#NYSE">LOW</a>), Intuit Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTU#NASDAQ">INTU</a>), and Union Pacific Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNP#NYSE">UNP</a>).
The International Sales Basket includes Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>), Broadcom Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>), Visa Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>), Mastercard Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MA#NYSE">MA</a>), QUALCOMM Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>), Netflix Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>), McDonald's Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>), Philip Morris Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>), Applied Materials Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>), and Intel Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>).
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/24/11/42103600/us-dollar-may-test-10860-level-as-geopolitical-tensions-cautious-fed-rhetoric-and-solid-us-economic-data-may-push-the-greenback-higher-says-expert">Dollar Upside On The Cards Amid Geopolitical Tensions, Cautious Fed And Solid US Economic Data, Says Expert</a></li>
</ul>
Image Via Shutterstock 
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.<a href="https://www.benzinga.com/apis?utm_source=benzinga.com&amp;utm_campaign=article-bottom" target="_blank" rel="noreferrer noopener"></a>

Global

Economics

AMAT

AVGO

INTC

INTU

NFLX

QCOM

TMUS

Mohamed El-Erian Warns Against Simplistic Narratives As Trump Plans Aggressive Tariff Strategy: 'The Issue Is Quite Complex'

<ul>
<li>Philip Morris International affiliate, Swedish Match, earned first-ever FDA authorization for a modified risk marketing claim and now is the first to achieve an FDA renewal</li>
<li>PMI affiliates have secured 13 of the 16 modified risk tobacco product (MRTP) authorizations that the FDA has granted, demonstrating the company's commitment to a smoke-free future.</li>
</ul>

Reported Earlier, Philip Morris International Affiliate Swedish Match Earns FDA Renewal For Modified Risk Snus Products

Barclays analyst Gaurav Jain maintains Philip Morris Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) with a Overweight and raises the price target from $145 to $155.

Barclays Maintains Overweight on Philip Morris Intl, Raises Price Target to $155

These ten large-cap stocks were the best performers in the last week. Are they in your portfolio?
<ol>
<li>Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) shares jumped 21.97% following the earnings<a href="https://www.benzinga.com//node/41537560" target="_blank" rel="noreferrer noopener"> beat and overall market strength</a>.</li>
<li>Li Auto Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LI#NASDAQ">LI</a>) shares increased 14.02% last week. The People's Bank of China <a href="https://www.benzinga.com//node/41547149" target="_blank" rel="noreferrer noopener">injected 700 billion yuan</a> ($98.36 billion) into the banking system through its one-year medium-term lending facility, keeping the rate steady at 2.0%.</li>
<li>Molina Healthcare Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOH#NYSE">MOH</a>) stock surged 12.36% after the company<a href="https://www.benzinga.com//node/41500855" target="_blank" rel="noreferrer noopener"> reported third-quarter results</a>.</li>
<li>Tapestry, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPR#NYSE">TPR</a>) shares gained 11.83% following a report alleging that a <a href="https://www.benzinga.com//node/41550527" target="_blank" rel="noreferrer noopener">judge blocked the company's proposed acquisition</a> of Capri Holdings Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPRI#NYSE">CPRI</a>). The company said it intends to appeal the decision.</li>
<li>Applovin Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>) gained 11.30% last week after several analysts <a href="https://www.benzinga.com/quote/APP/analyst-ratings" target="_blank" rel="noreferrer noopener">raised their price forecasts</a> on the stock.</li>
<li>Booz Allen Hamilton Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAH#NYSE">BAH</a>) shares gained 10.99% after reporting better-than-expected Q2 financial results and <a href="https://www.benzinga.com//node/41543105" target="_blank" rel="noreferrer noopener">strong FY25 guidance</a>.</li>
<li>Digital Realty Trust, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLR#NYSE">DLR</a>) shares upped 9.45% after reporting better-than-expected Q3 FFO results and raising FY24 FFO guidance. Several analysts <a href="https://www.benzinga.com/quote/DLR/analyst-ratings" target="_blank" rel="noreferrer noopener">raised their price forecasts</a> on the stock.</li>
<li>Grab Holdings Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRAB#NASDAQ">GRAB</a>) stock gained 9.12% last week. Daiwa Capital initiated coverage on the stock with an Outperform rating and <a href="https://www.benzinga.com/quote/GRAB/analyst-ratings" target="_blank" rel="noreferrer noopener">a $4.60 price target</a>.</li>
<li>MicroStrategy Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) shares were up <a href="https://www.benzinga.com//node/41544385" target="_blank" rel="noreferrer noopener">8.56% amid a rise in Bitcoin</a>.</li>
<li>Philip Morris International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) shares upped 8.03% after the company reported better-than-expected third-quarter results and several <a href="https://www.benzinga.com//node/41499153" target="_blank" rel="noreferrer noopener">analysts raised the price target</a>.</li>
</ol>
Photo via Shutterstock

Large Cap

Movers

CPRI

GRAB

MSTR

TSLA

Tesla, Li Auto And MicroStrategy Are Among Top 10 Large Cap Gainers Last Week (Oct 21-Oct 25): Are The Others In Your Portfolio?

WIIM

Philip Morris International shares are trading lower. Multiple insider sales were disclosed today.

Insider Trades

Philip Morris International Chairman Andre Calantzopoulos Sells 101,918 Shares Of Stock At An Average Price Of $129.85/Share

Stifel analyst Matthew E. Smith reiterated a Buy rating on Philip Morris International Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>), <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41475502/philip-morris-raised-guidance-suggests-good-visibility-goldman-sachs-analyst" rel="noreferrer noopener">raising the price forecast to $145 from $138.</a>
Yesterday, the Marlboro maker reported third-quarter revenue of $9.91 billion, up 8.4% year over year, beating the&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">consensus of $9.69 billion</a>.
Smith writes that growth in smoke-free products is driving both organic revenue growth and margin expansion.
Net revenues increased by 11.6% on an organic basis, mainly reflecting a favorable pricing variance, primarily due to higher combustible tobacco pricing, and a favorable volume/mix, mainly driven by higher smoke-free product volume.
Per Smith, there is a strong argument for owning the stock, thanks to the impressive and accelerating growth of IQOS and ZYN brands, which supports robust long-term business expansion.
The analyst highlighted that market share is growing steadily in important regions like Japan and Europe, with Europe&#8217;s share hitting 9.5% this quarter.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/24/10/41453988/marlboro-maker-philip-morris-highlights-strong-q3-performance-on-higher-prices-issues-upbeat-annual" rel="noreferrer noopener">Marlboro Maker Philip Morris Highlights Strong Q3 Performance On Higher Prices, Issues Upbeat Annual Forecast</a>
Most of the flavor bans in Europe are now in place, and Smith adds that the rebound in in-market sales (IMS)&nbsp;and market share shows promising growth potential for IQOS in the region.
Philip Morris has raised the low end of its U.S. ZYN volume outlook for 2024, now expecting 570 to 580 million cans, which is an increase of 10 million at the low end. The analyst estimates a total of 579 million cans, reflecting over 50% growth.
For 2025, the analyst estimates 9.5% EPS growth, driven by 8% organic revenue growth and margin expansion from smoke-free products.
This includes a 10% increase in organic operating profit, supported by volume growth and over 7 percentage points from price/mix contributions.
Price Action: PM shares are trading lower by 0.36% to $130.94 at last check Wednesday.
Photo by nawamin on Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41496025/general-motors-growth-potential-in-focus-amid-ev-transition-analyst-highlights-robu" target="_blank" rel="noreferrer noopener">General Motors Growth Potential In Focus Amid EV Transition: Analyst Highlights Robust Liquidity, More Buybacks</a></li>
</ul>

Analyst Color

Equities

Reiteration

Philip Morris' Q3 Driven By Smoke-Free Products Amid Rising Market Share In Key Regions: Analyst Forecasts Growth Across IQOS And ZYN Brands

JP Morgan analyst Jared Dinges maintains Philip Morris Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) with a Overweight and raises the price target from $125 to $145.

JP Morgan Maintains Overweight on Philip Morris Intl, Raises Price Target to $145

Stifel analyst Matthew Smith reiterates Philip Morris Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) with a Buy and raises the price target from $138 to $145.

Comments

Philip Morris Intl

空売り

Philip Morris Intl (NYSE:PM) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル